| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/31/1998 | US5733867 Cholecystokinins and gastrin antagonist |
| 03/31/1998 | US5733740 Taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
| 03/31/1998 | US5733568 Micro-encapsulated lactobacilli for medical applications |
| 03/31/1998 | CA2134889C Calcium channel blocking polypeptides from filistata hibernalis |
| 03/30/1998 | CA2216763A1 N-acylpiperazine derivative, anti-ulcer drug, and antibacterial drug |
| 03/26/1998 | WO1998012322A1 Bone morphogenetic protein-16 (bmp-16) compositions |
| 03/26/1998 | WO1998012211A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| 03/26/1998 | WO1998012177A1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 03/26/1998 | WO1998011901A1 Inositol polyphosphate derivatives and methods of using same |
| 03/26/1998 | WO1998011885A1 Reflux inhibitors |
| 03/26/1998 | WO1998011866A1 Mouthwash comprising calcium and phosphate ions in supersaturated solution |
| 03/26/1998 | WO1997043272A3 Benzofurans and benzopyrans as chronobiological agents |
| 03/26/1998 | CA2267348A1 Inositol polyphosphate derivatives and methods of using same |
| 03/25/1998 | EP0830863A1 Drugs for increasing gastrointestinal blood supply |
| 03/25/1998 | EP0830390A1 Hydrophobic heteroatom-containing sequestrant for cholesterol depletion |
| 03/25/1998 | EP0830377A1 Glucagon-like peptide-2 and its therapeutic use |
| 03/25/1998 | EP0830374A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 03/25/1998 | EP0830347A1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity |
| 03/25/1998 | EP0830138A1 Use of fibroblast growth factors to stimulate bone growth |
| 03/25/1998 | EP0830136A1 New cryptophycins from synthesis |
| 03/25/1998 | CN1177378A Stabilized external guide sequences |
| 03/25/1998 | CN1177357A Bismuth compound |
| 03/25/1998 | CN1177352A Prokinetic oxadiazoles |
| 03/25/1998 | CN1177343A Cell adhesion inhibitors |
| 03/25/1998 | CN1177299A Certain 1, 4, 5 -tri- substituted imidazole compounds useful as cytokine |
| 03/25/1998 | CN1177297A Medicament interded to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfuctions emesa and transport sickness |
| 03/25/1998 | CN1177292A Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate |
| 03/25/1998 | CN1176803A External application medicine for treating toothache due to saprodontia |
| 03/24/1998 | US5731351 Antiarrhythmia agents |
| 03/24/1998 | US5731350 Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/24/1998 | US5731340 Dietetics; antidiabetic agents |
| 03/24/1998 | US5731332 Leukotriene antagonists; antiinflammatory agents, antiallergens |
| 03/24/1998 | US5731306 Mercaptoacetylamido 1,3,4,5-tetrahydro-benzo c!azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 03/24/1998 | US5731302 Colloidal cellulose, hydrophilic thickener |
| 03/24/1998 | US5731293 Enzyme inhibitors |
| 03/24/1998 | US5731286 Cyclic neurokinin A antagonists |
| 03/24/1998 | US5731187 Process for preparing hepatitis A (HAV) antigens and vaccines |
| 03/24/1998 | US5731149 Antibiotic cryptdin peptides and methods of their use |
| 03/24/1998 | US5731006 Gastrointestinal mucosa-adherent granules, pharmaceutical preparations and a coating composition |
| 03/24/1998 | US5731002 Antisecretory |
| 03/24/1998 | US5730998 Administering substance p antagonist |
| 03/19/1998 | WO1998011119A1 Novel pyranoside derivatives |
| 03/19/1998 | WO1998011095A1 Substituted 2-pyrimidineamines, their preparation and their use as proteine kinase inhibitors |
| 03/19/1998 | WO1998011067A1 Preparation of 1-butyl-4-piperidinylmethylamine |
| 03/19/1998 | WO1998011062A1 Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect |
| 03/19/1998 | WO1998010783A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions |
| 03/19/1998 | WO1998010773A1 Pharmaceutical compositions with antimicrobial activity |
| 03/19/1998 | WO1998010770A1 Oral compositions containing fluocinonide |
| 03/19/1998 | DE19637123A1 Neue Pyranosidderivate New Pyranosidderivate |
| 03/19/1998 | CA2266028A1 Oral compositions containing fluocinonide |
| 03/19/1998 | CA2264748A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions |
| 03/18/1998 | EP0829481A1 Morphinan hydroxamic acid compounds |
| 03/18/1998 | EP0829480A2 Tetrazolyl-substituted quinuclidines as substance P antagonists |
| 03/18/1998 | EP0829470A1 2-Cyano-3,5-dihydroxy-hex-2-ene carboxamide derivatives, process for their preparation and their use as medicaments |
| 03/18/1998 | EP0828851A2 Tripeptidylpeptidase inhibitors |
| 03/18/1998 | EP0828833A1 Chemokine n-terminal deletion mutations |
| 03/18/1998 | EP0828756A2 Diagnosis of, and vaccination against, a positive stranded rna virus using an isolated, unprocessed polypeptide |
| 03/18/1998 | EP0828730A1 Piperazine derivatives |
| 03/18/1998 | EP0828724A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors |
| 03/18/1998 | EP0828712A1 Beta-adrenergic agonists |
| 03/18/1998 | EP0828509A1 Composition to improve digestibility and utilisation of nutrients |
| 03/18/1998 | EP0828502A2 Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field |
| 03/18/1998 | EP0828499A1 Micro-encapsulated lactobacilli for medical applications |
| 03/18/1998 | EP0828498A1 Chemotherapeutic compositions |
| 03/18/1998 | EP0828491A1 Aryl-imidazolines and aryl-imidazoles useful as alpha-2 adrenergic agonists without cardiovascular side effects |
| 03/18/1998 | EP0758225B1 Chewable anti-gastric acidity pastilles |
| 03/18/1998 | EP0739214B1 A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS |
| 03/18/1998 | CN1176137A Cane sugar-free notoginseng flower essence and its preparation |
| 03/18/1998 | CN1176123A Medicine for chronic hepatitis B and its preparation |
| 03/17/1998 | US5728846 Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives |
| 03/17/1998 | US5728845 Immunotherapeutic nitriles |
| 03/17/1998 | US5728844 Immunotherapeutic agents |
| 03/17/1998 | US5728829 Multistage reaction of n-protected benzotriazolyl glycine derivative with aminoketone, then reaction with ammonia and acid catalyzed cyclization |
| 03/17/1998 | US5728716 Trachykinin peptide for nervous system disorders and cardiovascular disorders |
| 03/17/1998 | US5728713 Use of quinoline-3-carboxamide compounds |
| 03/17/1998 | US5728711 Antiulcer agents |
| 03/17/1998 | US5728700 Sulfonamide compounds of azolones anti-helicobacter agents |
| 03/17/1998 | US5728695 Tachykinin antagonists useful in treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia |
| 03/17/1998 | US5728676 Use of insulin-like growth factors I and II for inhibition of inflammatory response |
| 03/17/1998 | US5728518 Soluble complex of a poly- or oligonucleotide and a carrier |
| 03/17/1998 | US5728380 Priobiotic containing enterococcus faecium strain NCIMB 40371 |
| 03/17/1998 | CA1339724C Anti-inflammatory factor, method of isolation, and use |
| 03/12/1998 | WO1998009992A2 HTm4, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS |
| 03/12/1998 | WO1998009985A2 Anti-inflammatory peptides and uses thereof |
| 03/12/1998 | WO1998009977A1 Tetrahydronapthalene derivatives and their therapeutic use |
| 03/12/1998 | WO1998009961A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 03/12/1998 | WO1998009940A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| 03/12/1998 | WO1998009934A1 Matrix metalloproteinase inhibitors and their therapeutic uses |
| 03/12/1998 | WO1998009626A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 03/12/1998 | WO1998009625A1 SELECTIVE β3 ADRENERGIC AGONISTS |
| 03/12/1998 | WO1998009599A2 The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives |
| 03/12/1998 | WO1998009533A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 03/12/1998 | WO1998009524A1 Methods and compositions for liver specific delivery of therapeutic molecules using recombinant aav vectors |
| 03/12/1998 | WO1997040854A3 Polypeptide conjugates for transporting substances across cell membranes |
| 03/12/1998 | DE19636689A1 Neue Benzamidinderivate New benzamidine derivatives |
| 03/12/1998 | CA2795629A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 03/12/1998 | CA2264798A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 03/12/1998 | CA2264737A1 Tetrahydronaphthalene derivatives and their therapeutic use |
| 03/12/1998 | CA2264490A1 Htm4, methods of treatment and assays, agonists and antagonists |
| 03/12/1998 | CA2264285A1 Anti-inflammatory peptides and uses thereof |